Centre for Population Health Sciences (CePHaS), Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Clinical Sciences Building, 11 Mandalay Road, Singapore, 308232, Singapore.
The Usher Institute, The University of Edinburgh, Edinburgh, EH8 9DX, Scotland, UK.
BMC Med. 2019 Jul 17;17(1):143. doi: 10.1186/s12916-019-1382-x.
Big data, coupled with the use of advanced analytical approaches, such as artificial intelligence (AI), have the potential to improve medical outcomes and population health. Data that are routinely generated from, for example, electronic medical records and smart devices have become progressively easier and cheaper to collect, process, and analyze. In recent decades, this has prompted a substantial increase in biomedical research efforts outside traditional clinical trial settings. Despite the apparent enthusiasm of researchers, funders, and the media, evidence is scarce for successful implementation of products, algorithms, and services arising that make a real difference to clinical care. This article collection provides concrete examples of how "big data" can be used to advance healthcare and discusses some of the limitations and challenges encountered with this type of research. It primarily focuses on real-world data, such as electronic medical records and genomic medicine, considers new developments in AI and digital health, and discusses ethical considerations and issues related to data sharing. Overall, we remain positive that big data studies and associated new technologies will continue to guide novel, exciting research that will ultimately improve healthcare and medicine-but we are also realistic that concerns remain about privacy, equity, security, and benefit to all.
大数据,加上人工智能(AI)等先进分析方法的使用,有可能改善医疗效果和人口健康。例如,从电子病历和智能设备中常规生成的数据,其收集、处理和分析变得越来越容易和廉价。近几十年来,这促使在传统临床试验环境之外的生物医学研究工作大量增加。尽管研究人员、资助者和媒体显然对此充满热情,但成功实施产品、算法和服务的证据很少,这些产品、算法和服务对临床护理产生了真正的影响。本论文集提供了如何利用“大数据”来促进医疗保健的具体示例,并讨论了此类研究中遇到的一些限制和挑战。它主要侧重于真实世界的数据,如电子病历和基因组医学,考虑了人工智能和数字健康方面的新发展,并讨论了与数据共享相关的伦理考虑和问题。总的来说,我们仍然对大数据研究和相关新技术持积极态度,认为它们将继续指导新颖、令人兴奋的研究,最终改善医疗保健和医学,但我们也现实地认识到,仍然存在隐私、公平、安全和造福所有人等方面的问题。